Get started
Author

Elisa Lucchini

Rituximab in the treatment of immune thrombocytopenia: what is the role of this agent in 2019?
2019 · Elisa Lucchini, Francesco Zaja, et al. · Haematologica · 117
PDF
Genetic and phenotypic attributes of splenic marginal zone lymphoma
2021 · Ferdinando Bonfiglio, Alessio Bruscaggin, et al. · Blood · 97
Short course of bortezomib in anemic patients with relapsed cold agglutinin disease: a phase 2 prospective GIMEMA study
2018 · Giuseppe Rossi, Doriana Gramegna, et al. · Blood · 91
PDF
Rituximab in immune thrombocytopenia: gender, age, and response as predictors of long‐term response
2016 · Miriam Marangon, Nicola Vianelli, et al. · European Journal Of Haematology · 91
Safety and efficacy of rilzabrutinib vs placebo in adults with immune thrombocytopenia: the phase 3 LUNA3 study
2025 · David J. Kuter, Waleed Ghanima, et al. · Blood · 61
Real-world use of thrombopoietin receptor agonists in older patients with primary immune thrombocytopenia
2021 · Francesca Palandri, Elena Rossi, et al. · Blood · 56
PDF
Eltrombopag second‐line therapy in adult patients with primary immune thrombocytopenia in an attempt to achieve sustained remission off‐treatment: results of a phase II, multicentre, prospective study
2021 · Elisa Lucchini, Francesca Palandri, et al. · British Journal of Haematology · 55
Omission of Radiotherapy in Primary Mediastinal B-Cell Lymphoma: IELSG37 Trial Results
2024 · Maurizio Martelli, Luca Ceriani, et al. · Journal of Clinical Oncology · 36
Venetoclax in combination with hypomethylating agents in previously untreated patients with acute myeloid leukemia ineligible for intensive treatment: a real-life multicenter experience
2022 · Eleonora De Bellis, Silvia Imbergamo, et al. · Leukemia Research · 31
PDF
Real-world Outcomes of Relapsed/Refractory Diffuse Large B-cell Lymphoma Treated With Polatuzumab Vedotin-based Therapy
2022 · Lisa Argnani, Alessandro Broccoli, et al. · HemaSphere · 28
Eltrombopag for immune thrombocytopenia secondary to chronic lymphoproliferative disorders: a phase 2 multicenter study
2019 · Carlo Visco, Francesco Rodeghiero, et al. · Blood · 23
PDF
Management of immune thrombocytopenia in elderly patients
2018 · Elisa Lucchini, Renato Fanin, et al. · European Journal of Internal Medicine · 22
Rituximab and Bendamustine (BR) Compared with Rituximab, Bendamustine, and Cytarabine (R-BAC) in Previously Untreated Elderly Patients with Mantle Cell Lymphoma
2021 · Giulia Bega, Jacopo Olivieri, et al. · Cancers · 15
PDF
Case Report: Cardiac Involvement by Lymphoma: Rare but Heterogeneous Condition With Challenging Behaviors
2021 · Elisa Lucchini, Marco Merlo, et al. · Frontiers in Oncology · 13
PDF
Immune Checkpoint Inhibitors in Combination with Radiotherapy as Salvage Treatment for Relapsed/Refractory Classical Hodgkin Lymphoma: A retrospective Analysis in 12 Patients
2021 · Elisa Lucchini, Chiara Rusconi, et al. · Hematology Reports · 12
PDF
Genetic and Phenotypic Attributes of Splenic Marginal Zone Lymphoma
2021 · F. Bonfiglio, A. Bruscaggin, et al. · Hematological Oncology · 12
PDF
Case report: Long-lasting SARS-CoV-2 infection with post-COVID-19 condition in two patients with chronic lymphocytic leukemia: The emerging therapeutic role of casirivimab/imdevimab
2022 · Laura Ballotta, Omar Simonetti, et al. · Frontiers in Oncology · 10
Addition of autologous stem-cell transplantation to an ibrutinib-containing first-line treatment in patients aged 18–65 years with mantle cell lymphoma (TRIANGLE): 4·5-year follow-up of a three-arm, randomised, open-label, phase 3 superiority trial of the European MCL Network
2026 · Martin Dreyling, Martin Dreyling, et al. · The Lancet · 9
Venetoclax Shows Low Therapeutic Activity in BCL2-Positive Relapsed/Refractory Peripheral T-Cell Lymphoma: A Phase 2 Study of the Fondazione Italiana Linfomi
2021 · Laura Ballotta, Pier Luigi Zinzani, et al. · Frontiers in Oncology · 9
PDF
Limited efficacy for ibrutinib and venetoclax in T-prolymphocytic leukemia: results from a phase 2 international study
2024 · Marco Herling, Claire Dearden, et al. · Blood Advances · 7
PDF
Successful treatment and FDG-PET/CT monitoring of HHV-6 encephalitis in a non-neutropenic patient: case report and literature review
2017 · Elda Righi, Alessia Carnelutti, et al. · Journal of NeuroVirology · 7
Real‐world efficacy and safety of fostamatinib in ITP patients: Italian multicentre experience. GIMEMA ITP1122 study
2025 · Elisa Lucchini, Nicola Vianelli, et al. · British Journal of Haematology · 6
Impact of immunochemotherapy regimens on outcomes of patients with primary mediastinal B-cell lymphoma in the IELSG37 trial
2025 · Emanuele Zucca, Luca Ceriani, et al. · Blood · 5
Teclistamab salvage therapy for multiple myeloma relapse after allogeneic hemopoietic stem cell transplant: A case report
2023 · Francesco Zaja, Elisa Lucchini, et al. · American Journal of Hematology · 4
PDF
Eltrombopag: More Than Just a Thrombopoietin Receptor Agonist (TPO-RA) in Immune Thrombocytopenia (ITP)
2019 · Anwar A. Sayed, Amna Malik, et al. · Blood · 4
Works count: 72
Citation count: 879
H-index: 14
I10-index: 18
Year
Topic
Type